Editorial Board Member
Alex Chang ZOU
School of Biomedical Sciences, The Chinese University of Hong Kong, China
About
As published by the journal they serve.
Alex Chang ZOU, is a qualified physician and treated both emergency and in-hospital patients with surgical disorders as in Dong Rui Hospital, Nanjing, China. He is presently working as Deputy Director in Clinical Research Centre. His previous research work includes: 1. Selection and validation of esophageal cancer cell targeting phage-displayed peptides. 2. Dose-effect curve study and new applications development of human recombinant endostatin. 3. Preclinical study of an anti-VEGF monoclonal antibody drug. Functional study of estrogen-related receptor alpha in prostate cancer. 4. Estrogen-related receptor alpha in Castration-Resistance Prostate Cancer. He also provided an original idea and prepared preliminary data for the grant applying and found that ERRï¡ overexpression in prostate cancer contribute to its Bicalutamide-resistance and androgen independent growth both in vitro and in vivo.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Developing DrugsEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
